Sanofi acquires DYNAVAX TECHNOLOGIES CORP (2026)

Deal facts

Buyer: Sanofi
Target: DYNAVAX TECHNOLOGIES CORP
Deal value: Not disclosed
Announced: 10 February 2026
Status: Completed
Sector: Technology
Country: United States
Consideration: cash

Sources

SEC_EDGAR_8K

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

10 Feb 2026CompletedClosed
Samba Merger Sub, Inc completes acquisition of DYNAVAX TECHNOLOGIES CORP
INTRODUCTORY NOTE As previously disclosed in the Current Report on Form 8-K filed with the Securities and Exchange Commission (“ SEC ”) by Dynavax Technologies Corporation, a Delaware corporation (the “ Company ”) on December 29, 2025, the Company entered into an Agreement and Plan of Merger, dated December 23, 2025 (the “ Merger Agreement ”), with SANOFI, a French société anonyme (“ Parent ”), an
Source

OpinionExit Mode editorial

We see a clear signal in the completed acquisition of DYNAVAX TECHNOLOGIES CORP by its parent. This going-private transaction, announced on 10 February 2026, removes a US technology firm from public markets using an all-cash consideration. The absence of a disclosed value or currency figure in the public record is notable, yet the mechanics are straightforward. A parent company has chosen to consolidate ownership rather than maintain a public listing for a subsidiary. This move often reflects a strategic desire to execute long-term plans without the quarterly scrutiny that public markets demand.

For the SME founder reading this, the shift from public to private is rarely about the immediate price tag alone. It is about control and the removal of regulatory friction. When a parent executes a going-private deal, they bypass the continuous disclosure obligations of the Securities and Exchange Commission. This allows for operational pivots that might confuse public investors but make sense for a unified group. The all-cash structure confirms that the buyer values certainty of closure over complex equity swaps. There are no earn-outs or deferred payments mentioned here, which suggests the parent has the liquidity to settle the deal outright and absorb the target fully into its balance sheet.

The regulatory context for such a domestic US transaction is generally lighter than a cross-border merger, yet the change-of-control covenants in the target's existing debt agreements will have been the primary commercial hurdle. The board of DYNAVAX TECHNOLOGIES CORP likely had to navigate fiduciary duties to ensure the cash offer was fair, even without a competing bid. This is a clean exit for shareholders who wanted liquidity, but it also signals that the parent believes the technology assets are more valuable as part of a private group than as a standalone public entity. The lack of a published valuation figure does not diminish the strategic intent.

You should review your own shareholder register this week to identify any debt covenants that trigger on a change of control. If you are considering a sale to a strategic buyer, ensure your term sheet explicitly states whether the consideration will be cash or equity, as this dictates your ability to walk away with liquidity immediately.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Technology deals More 2026 deals More going private deals More from Sanofi All M&A deals

Similar deals

Other Technology M&A activity tracked by Exit Mode.

8 May 2026CompletedTechnology

essensys Bidco Limited to acquire essensys plc

essensys Bidco Limited and essensys plc entered the Exit Mode archive.

Buyer: essensys Bidco Limited
Target: essensys plc
Deal value: Not disclosed
Deal type: going private

Read deal Technology deals going private deals United Kingdom deals

16 March 2026CompletedTechnology

Agero, Inc. to acquire Urgent.ly, Inc.

Agero, Inc. and Urgent.ly, Inc. entered the Exit Mode archive.

Buyer: Agero, Inc.
Target: Urgent.ly, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Technology deals going private deals United States deals

29 December 2025CompletedTechnology

Cvent Atlanta, LLC to acquire ON24, Inc.

Cvent Atlanta, LLC and ON24, Inc. entered the Exit Mode archive.

Buyer: Cvent Atlanta, LLC
Target: ON24, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Technology deals going private deals United States deals

23 December 2025CompletedTechnology

Novacap to acquire Integral Ad Science, Inc.

Novacap and Integral Ad Science, Inc. entered the Exit Mode archive.

Buyer: Novacap
Target: Integral Ad Science, Inc.
Deal value: USD 10.3
Deal type: going private

Read deal Technology deals going private deals United States deals

19 November 2025CompletedTechnology

Adobe Inc. to acquire SEMrush Holdings, Inc.

Adobe Inc. and SEMrush Holdings, Inc. entered the Exit Mode archive.

Buyer: Adobe Inc.
Target: SEMrush Holdings, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Technology deals going private deals United States deals

Buyer history

Sanofi

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive

Sanofi to acquire DYNAVAX TECHNOLOGIES CORP

Deal facts

Join Exit Mode Insider

Deal timeline

Browse adjacent archives

Similar deals

essensys Bidco Limited to acquire essensys plc

Agero, Inc. to acquire Urgent.ly, Inc.

Cvent Atlanta, LLC to acquire ON24, Inc.

Novacap to acquire Integral Ad Science, Inc.

Adobe Inc. to acquire SEMrush Holdings, Inc.

Sanofi

How this page is built